Suchergebnisse - "Reyes-García, Rebeca"

PubPharm (6)

1

Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis

enthalten in: Maturitas | 2015

von Morales-Santana, S. | Díez-Pérez, A. | Olmos, J. | +13

2

Treatment holidays in patients with postmenopausal osteoporosis : whom and when?

enthalten in: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion | 2012

von Reyes García, R. | García Martín, A. | Muñoz-Torres, M.

3

Clinical practice guidelines for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions. Bone Metabolism Working Group of the Spanish Society of Endocrinology

enthalten in: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion | 2012

von Reyes García, R. | Jódar Gimeno, E. | García Martín, A. | +17

ErratumIn: Endocrinol Nutr. 2012 Aug-Sep;59(7):469

4

Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate

enthalten in: Menopause (New York, N.Y.) | 2012

von Sebastián-Ochoa, A. | Fernández-García, D. | Reyes-García, R. | +4

5

Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis

enthalten in: Menopause (New York, N.Y.) | 2010

von Reyes-García, R. | Muñoz-Torres, M. | García, D. | +3

6

Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate

enthalten in: Maturitas | 2009

von Muñoz-Torres, M. | Reyes-García, R. | Mezquita-Raya, P. | +5

1
[1]